短发卡状RNA抑制AKT2基因治疗肝癌的实验研究
|
摘要
原发性肝癌是常见的消化系统恶性肿瘤,约占消化系统肿瘤的20%以上,其中肝细胞肝癌约占90%,其生物学特征为易复发、转移、预后差、死亡率高。尽管目前原发性肝癌的治疗方案(手术切除、介入治疗、生物治疗、激光及微波治疗等)日趋完善,但仍难以取得令人满意的疗效,患者生存期极短。因此研究肝癌的发病机理以及探讨新的可行的治疗方案具有极其重要的临庆意义。
随着肿瘤学领域中基础研究的不断深入,近年来信号传导通路在肿瘤发生过程中的异常改变及其导致细胞生长失控的机制成为研究的热点。研究发现磷脂酞肌醇3激酶(PI3K)/蛋白激酶B(AKT)信号传导通路在肿瘤的发生、发展、凋亡、血管生成、转移及耐药等方面起着重要的作用。而AKT2作为PI3K/ AKT2信号转导通路的关键分子,在其中更是起着核心的作用。而多种人类恶性肿瘤主要表达AKT家族中的AKT2。细胞内高表达AKT2或激活AKT2的蛋白激酶活性能阻止细胞发生凋亡,增强肿瘤细胞的侵袭能力。
目前,国内针对AKT2基因表达与肝细胞癌分化程度、生长方式、临床特点及转移活性的关系尚未进行深入系统的研究。针对AKT2利用小干扰RNA基因治疗肝癌尚无报道。本课题从三个角度进行了系统研究:①肝癌组织AKT2基因表达与肝癌恶性程度、临床特点、转移活性的相关性和在肝癌细胞中的表达。②采用脂质体体外转染针对AKT2的小干扰RNA,并建立稳定株观察转染后肿瘤细胞在体外的生长情况及产生的可能机制。③AKT2小干扰RNA转染后肿瘤细胞体内生长情况观察。
结果将为探讨以AKT2为靶点并结合小干扰RNA进行基因治疗,阻止肿瘤的发生和发展,提高生存率,延长生存期奠定理论基础。
第一部分AKT2在肝癌组织、肝癌细胞系中的表达及意义
本研究对32对肝细胞癌(HCC),4例正常肝组织、4株肝癌细胞株用RT-PCR反应、免疫组化法分别检测AKT2mRNA表达和蛋白表达的情况;分析肝癌AKT2基因表达与肿瘤分期、转移等临床指标之间的关系。
1通过RT-PCR方法检测32对人肝细胞癌、4例正常肝脏组织AKT2mRNA表达水平:发现肝癌组织AKT2mRNA的表达明显高于癌旁组织,其中有28对上调,所占比率高达62.5%(P<0.05)。其中4对接近有和无的关系。正常肝中没表达。此外发现:瘤栓组AKT2mRNA表达水平为0.59±0.01,无瘤栓组为0.29±0.02;肝内转移组AKT2mRNA表达水平为0.62±0.03,无肝内转移组为0.30±0.02,相应的两组之间有显著差异。此结果表明AKT2mRNA表达水平增高与临床上肿瘤的侵袭特性有关。
2采用免疫组化法检测AKT2蛋白在32例标本中的表达发现在62.5%(28/32例)的肝癌组织内可见到AKT2阳性表达,AKT2阳性表达颗粒主要位于胞膜和胞浆,在同一组织标本中AKT2表达呈现均一性。AKT2的表达在不同分化程度的肝癌有显著差异(P<0.05),高分化肝癌的表达率和表达强度显著低于中分化、低分化肝癌。在肿瘤大小、肝内转移阳性组和阴性组、有和无门静脉癌栓组、HBsAg阳性组和阴性组间有显著性差异(P<0.05)。而与患者的年龄、性别无显著相关性(P>0.05)。
3利用Western-blot技术检测AKT2基因在4株肝癌细胞株中的表达,发现肝癌细胞株SMMC-7721AKT2的表达最明显。
由此可见,AKT2在肝癌的发生、发展和转移中发挥重要作用,抑制AKT2基因的表达将起到控制肿瘤生长的目的。
第二部分封闭人肝癌AKT2的siRNA片段设计、筛选、真核表达载体的构建及SMMC7721细胞转染条件的优化
1在哺乳动物细胞的siRNA研究中,有两个关键的步骤,即如何筛选出最有效的针对目标基因的siRNA片段,并使其高效转染入哺乳动物细胞内和表达。本实验通过网上的siRNA设计软件,设计针对AKT2的特异性siRNA。
2质粒的扩增、提取及鉴定:采用DH5α大肠杆菌为工作菌,制备感受态细胞,扩增质粒,提取质粒DNA,并经酶切鉴定以备转染使用。
3转染效率与脂质体的量和质粒量存在交互作用。在6孔板中以Lipofectamine2000 10μl,质粒量4.0ug时转染效率最高,达到85%以上。Lipofectamine2000转染中可以看到随着转染时间的延长,细胞毒性加大,大于8小时后,转染效率并没有增加。最大的转染效率和最小的细胞毒性的平衡点在8小时。
4瞬时转染1,2,3,4,5,6天各组细胞的AKT2的mRNA的变化RT-PCR显示,第3天的时候达到高峰,AKT2的mRNA明显减少,而阴性对照组、空白组AKT2的mRNA没有明显变化。Western-blot检测提示,随着时间的延长,AKT2蛋白在第4天达到被封闭的高峰,而阴性对照组、空白组AKT2的蛋白的变化无显著的差异。研究结果提示:采用脂质体Lipofectamine2000可以成功的将AKT2-siRNA转入SMMC7721细胞中,使后者AKT2mRNA及蛋白的表达受到抑制为进一步观察肿瘤细胞的生物学变化打下基础。
第三部分AKT2-siRNA对SMMC7721细胞生物学的影响
鉴于第一部分结果显示AKT2在肝癌组织中呈过度表达现象,并且与肿瘤恶性程度、转移能力呈正相关。所以,以AKT2基因为优选靶,采用小干扰RNA技术,抑制AKT2基因表达,将会减少肝癌恶性表型,为肝癌的治疗带来希望。
1利用高表AKT2mRNA及蛋白的肝癌细胞系(简称7721细胞)为体外细胞系模型,建立分别含有Supersilencing-AKT2-siRNA、GFP质粒的稳定细胞株。应用MTT法检测细胞生长曲线发现Supersilencing-AKT2-siRNA细胞的生长明显缓慢。应用流式细胞仪检测细胞的细胞周期,发现干扰组S期细胞百分率明显低于对照组(P<0.05),而G0/G1期细胞百分率则明显高于对照组(P<0.05)。Western-blot结果提示干扰组CyclinD1、P27、P21的表达明显低于对照组(P<0.05)。以上说明抑制AKT2基因的表达能够明显降低肝癌细胞的增殖。
2利用粘附实验发现干扰组细胞的粘附能力明显下降。通过计算2小时后粘附在平皿上的细胞OD值,我们可以看出,干扰组粘附能力下降约3倍左右。划线实验和Transwell实验都提示干扰组细胞的的侵袭能力明显下降了。明胶酶法检测细胞株MMP-2、MMP-9的结果,可以看到封闭AKT2的表达明显抑制了肝癌细胞MMP-2、MMP-9的表达。从Western-blot可以看到干扰组、LNR、ICAM-Ⅰ在蛋白水平的变化的表达明显低于对照组, E-cadherin在蛋白水平变化明显高于对照组(P<0.05)。
研究结果提示:通过靶向阻断AKT2蛋白的表达可以抑制SMMC7721癌细胞株的生长和转移。
第四部分封闭AKT2蛋白表达促人肝癌细胞凋亡作用实验研究
AKT2的表达与肿瘤的凋亡抑制密切相关,这决定了AKT2在肝癌的靶向治疗上可能具有独特的价值。为了进一步探讨靶向抑制AKT2在肝细胞癌治疗中的意义和价值,我们观察其对肝癌细胞凋亡和化疗药物敏感性的影响。
1在CHX(放线菌酮)诱导凋亡后,显微镜下可以观察到干扰组细胞较对照组细胞形态变化明显,表现为细胞间隙逐渐加大,部分细胞边缘变钝;贴壁性能差;易于脱落;死亡细胞较多见。应用DAPI染色显示实验组细胞凋亡明显增加,差异有显著性(P<0.05)。用流式细胞仪检测细胞凋亡,发现CHX处理24小时后可不同程度地诱导三组细胞凋亡,干扰组细胞凋亡数(34.2±4.4%)明显高于各对照组,(16.7±1.8%),(20.4±2.1%)(P<0.05)。而对照组间比较无显著性差异(P>0.05)。本结果表明,AKT2-shRNA可抑制肿瘤细胞生长,增强肿瘤细胞对凋亡药物的敏感性。
2在蛋白水平上,CHX诱导凋亡后,干扰组Bax蛋白,Caspase3蛋白表达比对照组明显上调,而Bcl-2蛋白表达明显下降。
3用等浓度化疗药物吉西他滨处理发现干扰组细胞生长抑制率明显高于对照组细胞,组间差异有显著性(P<0.05)。
由此我可以得出结论AKT2-shRNA可以增加肝癌细胞的凋亡易感性,为进一步的体内实验打下基础。
第五部分AKT2小干扰RNA对肝癌细胞体内生长的影响
为了进一步揭示AKT2在肝癌的发生、发展中的作用,观察AKT2小干扰RNA转染后的细胞体内生长情况,我们选用BALB-C裸鼠进行了体内实验观察。裸小鼠15只,随机分为3组:A.空白对照组5只:B.空载体组5只;C转染AKT2-siRNA基因组5只。于每只裸鼠腹部的前肢皮下分别接种等量的不同转染细胞(5×106/100ul/只),接种6周后终止实验。①观察肿瘤的生长情况:实验组裸鼠的肿瘤形成与对照组相比潜伏期长,平均为22.2±1.9天,对照组及反义组肿瘤形成的潜伏期分别为13.2±1.5天、10.6±1.5天,干扰组肿瘤形成时间明显被推迟,P<0.05。同时实验组裸鼠肿瘤的生长速度慢于对照组。实验结束时实验组为421.3±30.6mm3而对照组为932.59±48.7 mm3、887.36±38.5 mm3,(P<0.05)。结果说明,AKT2小干扰RNA有效地推迟和抑制了SMMC7721细胞在裸鼠体内肿瘤的形成和生长。②透射电镜观察:干扰组细胞可见到较多的外形变圆,体积缩小,染色深,表面出芽,染色质边集,表现出明显的凋亡细胞的形态。
本研究进一步揭示AKT2在肝癌的发生、发展中的作用,表明AKT2小干扰RNA基因治疗能有效地抑制肿瘤细胞在动物体内的生长速度。以此基因为靶基因进行小干扰RNA基因治疗,将有可能为人类肝癌提供有效的治疗手段。
Liver cancer is one of the common types of gastrointestinal tumors with poor prognosis metastasis and high mortality in which hepatocellular carcinoma(HCC)accounts for about 90%. Although the different available multi-modalities of therapies,including radical surgical operation、intervention therapy、laser therapy et al,have currently been used in the treatment for liver cancer,the prognosis of liver cancer has not been markedly improved. Therefore, it has an important clinic significance to study on the mechanism of the development and progression of liver cancer and the new strategies for the treatment of liver cancer with the molecular biology. With the development of the basic research on oncological fields, it was found that singal conduction has the focus.It was researched that PI3K/AKT singal conduction takes an important role in the growth、differentiation、angiogenesis、metastasis、proliferation of tumors. AKT2 is the key point in the PI3K/AKT singal conduction.It is an important factor. many tumors have the over expression in the AKT2 gene. The high expression of AKT2 and the action of AKT2 protein kinase can prevent the cell apoptosis and increase the invasion of cancer cell. By now,the systemic researches on the relationship between the expression of AKT2 and histopathologic type, metastasis activity、angiogenesis of HCC have not been reported. And there are also no reports on gene therapy against angiogeneis of liver cancer. This study contains three parts of work: The first, the relationships between the expression of AKT2 in HCC and the tumor grade,tumor metastasis,angiogenesis of liver cancer. The second the inhibitory effect of AKT2 small interfere RNA on the growth of 7721 hepatocellular cell line (7721 cancer hepatocytes)in vivo. The third,the inhibitory effect of AKT2 small interfere RNA on 7721 cell in nude mouse.
Part I:Study on the expression of AKT2 and its relationship to metastasis activity and angiogenesis of human HCC
1 Expression of AKT2 gene in human HCC and normal liver tissue.The gene expression of AKT2 in 32 pair human HCCs and 4 normal liver were studied by RT-PCR method.The expressive rates of HCCs and normal tissue were 62.5%and 0% respectively.4 paired samples are yes or no.Moreover,The levels of AKT2 mRNA(AKT2 mRNA/GAPDH mRNA)were 0.59±0.01 in embolus, 0.62±0.03 in metastasis respectively.The difference between them are significant.
The expression levels of AKT2 mRNA were positively correlated to pathologic grades、embolus and envelops of tumors.
2 The protein expression of AKT2 in human HCC and normal liver tissue.The protein expression of AKT2 in 32 paired human HCCs and 4 normal liver were studied by immunohistochemistry.The expression rates of HCCs and normal tissue were62.5% and 0% respectively.The level of AKT2 protein was also significantly correlated to pathologic grades、embolus、capsules and HBsAg of the tumors.
3 the expression of AKT2 in 4 cell lines were studied by Western-blot method.4 cell lines were all expressed,especially SMMC-7721.We find AKT2 are expressed in cytoplasm and cytomembrane mainly.It suggested that the AKT2 gene play an important role in the malignant progression of cancers.The overexpression of AKT2 and the correlation between AKT2 expression and tumor grade provided a useful parameter for evaluating the degree of malignancy at molecular level and for selecting the target gene in gene therapy.
PartⅡstudy on designing siRNA of blocking AKT2 expression,construction expression vector and optimizing transfection conditions
In studying siRNA of mammal cells,there are two key steps.One is to select effctive sequence of siRNA,the other is to transfer the sequences into cells effectively.We design the sequence in network.
1 there is interaction between Liposome2000 quantity and plasmid quantity in transfection.There is highest efficiency when Lipofectamine2000 volume is 10ul and the palsmid of quantity is 4ug.The efficiency is over 85%. Transfection time is longer,cell cytotoxicity is bigger.The best time is 8 hours after transfection,the biggest transfection,the biggest transfection efficiency and the lest cell cytotoxicity.
2 In the siRNA experiment we find the AKT2mRNA is lowest on the thirdth day by RT-PCR,but the AKT2 mRNA is not marked changed in the control teams.
We also find the AKT2 protein is lowest on the fourth day by Western-blot but the AKT2 protein is not marked changed in the control teams.The plasmid, Supersilencing- AKT2–siRNA is more,AKT2 protein is lowest.We can draw the conclusion:the plasmid can be transferred into SMMC7721 cell efficiently and AKT2mRNA or AKT2 ptotein is induced.
PartⅢThe inhibitory effect of AKT2-siRNA on the growth of HCC cells in vitro
Because there was no effective treatments on liver cancers,it is very urgent and important to find out new methods to solve this problem.According to the results in part I,we believed that AKT2 gene be a target in gene therapy of cancers.So we planed to utilize small interfere RNA technique to observe the inhibitory effects of small interfere RNA AKT2 mRNA on the expression of AKT2.
1 We confirmed a/the overexpression of AKT2 in 7721 HCC cells by RT-PCR analysis and immunohistochemistry.We use 7721 HCC cells to Stable cell line which has plasmid Supersilencing-AKT2-siRNA or Supersilencing–AKT2-GFP growth rate among these groups had differences detected by MTT assay.
2 The cell cycle is analysizd by FCM assay.The S stage of experimental team is longer than control team(P<0.05)but G0/G1 stage is shorter.The expression of CyclinD1、P27、P21 are reduced magnificently in experimental team by western-blot analysis.
3 In adhesion experiment we find the adhesion capability of SMMC7721-siRNA cell is decreased 3 times or so.SMMC7721-siRNA cell invasion is decreased by Scribing test and Transwell test.blocking AKT2 also reduced the decreasing of expression of MMP-2、MMP-9.we find the expression of LNR and ICAM-Ⅰare inhibited marked in SMMC7721-siRNA cell line. but E-cadherin is increased markedly.
We can draw the conclusion:blocking of AKT2 expression can inhibit growth and metastasis of SMMC7721-siRNA cell line.
PartⅣstudy on blocking AKT2 protein expression to promote SMMMC7721 Apoptosis
AKT2 is related to tumor Apoptosis closely.In order to study the value of AKT2 in gene theraphy,we observe the relationship between AKT2 and chemotherapeutics.
Induction Apoptosis by CHX,we can see Apoptosis cell is increased in SMMC7721-siRNA cell line.By DAPI analysis,the Apoptosis rate is decreased markedly in in SMMC7721-siRNA cell line.(P<0.05)
1 SMMC7721-AKT2-siRNA cell line processed with CHX for 24 hour,we find the apoptotic index (34.2%)is higher than control team(16.7%,20.4%).(P<0.05) by FCM.Outcome make it clear that blocking AKT2 can inhibit cell growth and enhance it sensitivity to chemotherapeutics.
2 Processed with CHX,we find the protein Bax,Caspase3 of SMMC7721- AKT2-siRNA cell lines up-regulated(P<0.05),meanwhile Bcl-2 is downregulated by western-blot.
3 Using equidensity chemotherapeutics Gem,we see growth inhibiting of SMMC7721-AKT2-siRNA cell line is higher than control team.(P<0.05). From above,we know blocking AKT2 can increase apoptositic sensitivity of hepatoma carcinoma cell to chemotherapeutics.This is foundation to the next in vivo experiment. PartⅤThe therapeutic effect of AKT2 small interfere RNA for HCC 7721 cells in vivo
In order to make further investigation on the role of AKT2 gene in the development of liver cancer and the effect of siRNA gene therapy in vivo,we carried out vivo study with BALB/nu/nu nude mice.15 nude mice were randomly divided into three groups and three prepared cells were subcutaneously injected on the back of mice:(1)control group:10 mice injected with wild-type 7721 HCC cells;(2) positive control group:5 mice injected with 7721 HCC cells transfected with plasmid GFP (3)experimental group:5 mice injected with 7721 HCC cells transfected with AKT2 small interfere RNA.The results showed:the transfected group were significently lower than that of positive control group and control group in volume、growth rate of tumors.In the tumors of experimental group, we knew that AKT2 protein were effectively blocked through analysis of wetern-blot.
The present study demonstrated that AKT2 play an important role in the angiogenesis and development of HCC,clarified the therapeutic effect of AKT2 siRNA in vivo and suggested that AKT2 gene be a target for small interfere RNA gene therapy of liver cancer.We get a useful theory basis for gene therapy of liver cance
随着肿瘤学领域中基础研究的不断深入,近年来信号传导通路在肿瘤发生过程中的异常改变及其导致细胞生长失控的机制成为研究的热点。研究发现磷脂酞肌醇3激酶(PI3K)/蛋白激酶B(AKT)信号传导通路在肿瘤的发生、发展、凋亡、血管生成、转移及耐药等方面起着重要的作用。而AKT2作为PI3K/ AKT2信号转导通路的关键分子,在其中更是起着核心的作用。而多种人类恶性肿瘤主要表达AKT家族中的AKT2。细胞内高表达AKT2或激活AKT2的蛋白激酶活性能阻止细胞发生凋亡,增强肿瘤细胞的侵袭能力。
目前,国内针对AKT2基因表达与肝细胞癌分化程度、生长方式、临床特点及转移活性的关系尚未进行深入系统的研究。针对AKT2利用小干扰RNA基因治疗肝癌尚无报道。本课题从三个角度进行了系统研究:①肝癌组织AKT2基因表达与肝癌恶性程度、临床特点、转移活性的相关性和在肝癌细胞中的表达。②采用脂质体体外转染针对AKT2的小干扰RNA,并建立稳定株观察转染后肿瘤细胞在体外的生长情况及产生的可能机制。③AKT2小干扰RNA转染后肿瘤细胞体内生长情况观察。
结果将为探讨以AKT2为靶点并结合小干扰RNA进行基因治疗,阻止肿瘤的发生和发展,提高生存率,延长生存期奠定理论基础。
第一部分AKT2在肝癌组织、肝癌细胞系中的表达及意义
本研究对32对肝细胞癌(HCC),4例正常肝组织、4株肝癌细胞株用RT-PCR反应、免疫组化法分别检测AKT2mRNA表达和蛋白表达的情况;分析肝癌AKT2基因表达与肿瘤分期、转移等临床指标之间的关系。
1通过RT-PCR方法检测32对人肝细胞癌、4例正常肝脏组织AKT2mRNA表达水平:发现肝癌组织AKT2mRNA的表达明显高于癌旁组织,其中有28对上调,所占比率高达62.5%(P<0.05)。其中4对接近有和无的关系。正常肝中没表达。此外发现:瘤栓组AKT2mRNA表达水平为0.59±0.01,无瘤栓组为0.29±0.02;肝内转移组AKT2mRNA表达水平为0.62±0.03,无肝内转移组为0.30±0.02,相应的两组之间有显著差异。此结果表明AKT2mRNA表达水平增高与临床上肿瘤的侵袭特性有关。
2采用免疫组化法检测AKT2蛋白在32例标本中的表达发现在62.5%(28/32例)的肝癌组织内可见到AKT2阳性表达,AKT2阳性表达颗粒主要位于胞膜和胞浆,在同一组织标本中AKT2表达呈现均一性。AKT2的表达在不同分化程度的肝癌有显著差异(P<0.05),高分化肝癌的表达率和表达强度显著低于中分化、低分化肝癌。在肿瘤大小、肝内转移阳性组和阴性组、有和无门静脉癌栓组、HBsAg阳性组和阴性组间有显著性差异(P<0.05)。而与患者的年龄、性别无显著相关性(P>0.05)。
3利用Western-blot技术检测AKT2基因在4株肝癌细胞株中的表达,发现肝癌细胞株SMMC-7721AKT2的表达最明显。
由此可见,AKT2在肝癌的发生、发展和转移中发挥重要作用,抑制AKT2基因的表达将起到控制肿瘤生长的目的。
第二部分封闭人肝癌AKT2的siRNA片段设计、筛选、真核表达载体的构建及SMMC7721细胞转染条件的优化
1在哺乳动物细胞的siRNA研究中,有两个关键的步骤,即如何筛选出最有效的针对目标基因的siRNA片段,并使其高效转染入哺乳动物细胞内和表达。本实验通过网上的siRNA设计软件,设计针对AKT2的特异性siRNA。
2质粒的扩增、提取及鉴定:采用DH5α大肠杆菌为工作菌,制备感受态细胞,扩增质粒,提取质粒DNA,并经酶切鉴定以备转染使用。
3转染效率与脂质体的量和质粒量存在交互作用。在6孔板中以Lipofectamine2000 10μl,质粒量4.0ug时转染效率最高,达到85%以上。Lipofectamine2000转染中可以看到随着转染时间的延长,细胞毒性加大,大于8小时后,转染效率并没有增加。最大的转染效率和最小的细胞毒性的平衡点在8小时。
4瞬时转染1,2,3,4,5,6天各组细胞的AKT2的mRNA的变化RT-PCR显示,第3天的时候达到高峰,AKT2的mRNA明显减少,而阴性对照组、空白组AKT2的mRNA没有明显变化。Western-blot检测提示,随着时间的延长,AKT2蛋白在第4天达到被封闭的高峰,而阴性对照组、空白组AKT2的蛋白的变化无显著的差异。研究结果提示:采用脂质体Lipofectamine2000可以成功的将AKT2-siRNA转入SMMC7721细胞中,使后者AKT2mRNA及蛋白的表达受到抑制为进一步观察肿瘤细胞的生物学变化打下基础。
第三部分AKT2-siRNA对SMMC7721细胞生物学的影响
鉴于第一部分结果显示AKT2在肝癌组织中呈过度表达现象,并且与肿瘤恶性程度、转移能力呈正相关。所以,以AKT2基因为优选靶,采用小干扰RNA技术,抑制AKT2基因表达,将会减少肝癌恶性表型,为肝癌的治疗带来希望。
1利用高表AKT2mRNA及蛋白的肝癌细胞系(简称7721细胞)为体外细胞系模型,建立分别含有Supersilencing-AKT2-siRNA、GFP质粒的稳定细胞株。应用MTT法检测细胞生长曲线发现Supersilencing-AKT2-siRNA细胞的生长明显缓慢。应用流式细胞仪检测细胞的细胞周期,发现干扰组S期细胞百分率明显低于对照组(P<0.05),而G0/G1期细胞百分率则明显高于对照组(P<0.05)。Western-blot结果提示干扰组CyclinD1、P27、P21的表达明显低于对照组(P<0.05)。以上说明抑制AKT2基因的表达能够明显降低肝癌细胞的增殖。
2利用粘附实验发现干扰组细胞的粘附能力明显下降。通过计算2小时后粘附在平皿上的细胞OD值,我们可以看出,干扰组粘附能力下降约3倍左右。划线实验和Transwell实验都提示干扰组细胞的的侵袭能力明显下降了。明胶酶法检测细胞株MMP-2、MMP-9的结果,可以看到封闭AKT2的表达明显抑制了肝癌细胞MMP-2、MMP-9的表达。从Western-blot可以看到干扰组、LNR、ICAM-Ⅰ在蛋白水平的变化的表达明显低于对照组, E-cadherin在蛋白水平变化明显高于对照组(P<0.05)。
研究结果提示:通过靶向阻断AKT2蛋白的表达可以抑制SMMC7721癌细胞株的生长和转移。
第四部分封闭AKT2蛋白表达促人肝癌细胞凋亡作用实验研究
AKT2的表达与肿瘤的凋亡抑制密切相关,这决定了AKT2在肝癌的靶向治疗上可能具有独特的价值。为了进一步探讨靶向抑制AKT2在肝细胞癌治疗中的意义和价值,我们观察其对肝癌细胞凋亡和化疗药物敏感性的影响。
1在CHX(放线菌酮)诱导凋亡后,显微镜下可以观察到干扰组细胞较对照组细胞形态变化明显,表现为细胞间隙逐渐加大,部分细胞边缘变钝;贴壁性能差;易于脱落;死亡细胞较多见。应用DAPI染色显示实验组细胞凋亡明显增加,差异有显著性(P<0.05)。用流式细胞仪检测细胞凋亡,发现CHX处理24小时后可不同程度地诱导三组细胞凋亡,干扰组细胞凋亡数(34.2±4.4%)明显高于各对照组,(16.7±1.8%),(20.4±2.1%)(P<0.05)。而对照组间比较无显著性差异(P>0.05)。本结果表明,AKT2-shRNA可抑制肿瘤细胞生长,增强肿瘤细胞对凋亡药物的敏感性。
2在蛋白水平上,CHX诱导凋亡后,干扰组Bax蛋白,Caspase3蛋白表达比对照组明显上调,而Bcl-2蛋白表达明显下降。
3用等浓度化疗药物吉西他滨处理发现干扰组细胞生长抑制率明显高于对照组细胞,组间差异有显著性(P<0.05)。
由此我可以得出结论AKT2-shRNA可以增加肝癌细胞的凋亡易感性,为进一步的体内实验打下基础。
第五部分AKT2小干扰RNA对肝癌细胞体内生长的影响
为了进一步揭示AKT2在肝癌的发生、发展中的作用,观察AKT2小干扰RNA转染后的细胞体内生长情况,我们选用BALB-C裸鼠进行了体内实验观察。裸小鼠15只,随机分为3组:A.空白对照组5只:B.空载体组5只;C转染AKT2-siRNA基因组5只。于每只裸鼠腹部的前肢皮下分别接种等量的不同转染细胞(5×106/100ul/只),接种6周后终止实验。①观察肿瘤的生长情况:实验组裸鼠的肿瘤形成与对照组相比潜伏期长,平均为22.2±1.9天,对照组及反义组肿瘤形成的潜伏期分别为13.2±1.5天、10.6±1.5天,干扰组肿瘤形成时间明显被推迟,P<0.05。同时实验组裸鼠肿瘤的生长速度慢于对照组。实验结束时实验组为421.3±30.6mm3而对照组为932.59±48.7 mm3、887.36±38.5 mm3,(P<0.05)。结果说明,AKT2小干扰RNA有效地推迟和抑制了SMMC7721细胞在裸鼠体内肿瘤的形成和生长。②透射电镜观察:干扰组细胞可见到较多的外形变圆,体积缩小,染色深,表面出芽,染色质边集,表现出明显的凋亡细胞的形态。
本研究进一步揭示AKT2在肝癌的发生、发展中的作用,表明AKT2小干扰RNA基因治疗能有效地抑制肿瘤细胞在动物体内的生长速度。以此基因为靶基因进行小干扰RNA基因治疗,将有可能为人类肝癌提供有效的治疗手段。
Liver cancer is one of the common types of gastrointestinal tumors with poor prognosis metastasis and high mortality in which hepatocellular carcinoma(HCC)accounts for about 90%. Although the different available multi-modalities of therapies,including radical surgical operation、intervention therapy、laser therapy et al,have currently been used in the treatment for liver cancer,the prognosis of liver cancer has not been markedly improved. Therefore, it has an important clinic significance to study on the mechanism of the development and progression of liver cancer and the new strategies for the treatment of liver cancer with the molecular biology. With the development of the basic research on oncological fields, it was found that singal conduction has the focus.It was researched that PI3K/AKT singal conduction takes an important role in the growth、differentiation、angiogenesis、metastasis、proliferation of tumors. AKT2 is the key point in the PI3K/AKT singal conduction.It is an important factor. many tumors have the over expression in the AKT2 gene. The high expression of AKT2 and the action of AKT2 protein kinase can prevent the cell apoptosis and increase the invasion of cancer cell. By now,the systemic researches on the relationship between the expression of AKT2 and histopathologic type, metastasis activity、angiogenesis of HCC have not been reported. And there are also no reports on gene therapy against angiogeneis of liver cancer. This study contains three parts of work: The first, the relationships between the expression of AKT2 in HCC and the tumor grade,tumor metastasis,angiogenesis of liver cancer. The second the inhibitory effect of AKT2 small interfere RNA on the growth of 7721 hepatocellular cell line (7721 cancer hepatocytes)in vivo. The third,the inhibitory effect of AKT2 small interfere RNA on 7721 cell in nude mouse.
Part I:Study on the expression of AKT2 and its relationship to metastasis activity and angiogenesis of human HCC
1 Expression of AKT2 gene in human HCC and normal liver tissue.The gene expression of AKT2 in 32 pair human HCCs and 4 normal liver were studied by RT-PCR method.The expressive rates of HCCs and normal tissue were 62.5%and 0% respectively.4 paired samples are yes or no.Moreover,The levels of AKT2 mRNA(AKT2 mRNA/GAPDH mRNA)were 0.59±0.01 in embolus, 0.62±0.03 in metastasis respectively.The difference between them are significant.
The expression levels of AKT2 mRNA were positively correlated to pathologic grades、embolus and envelops of tumors.
2 The protein expression of AKT2 in human HCC and normal liver tissue.The protein expression of AKT2 in 32 paired human HCCs and 4 normal liver were studied by immunohistochemistry.The expression rates of HCCs and normal tissue were62.5% and 0% respectively.The level of AKT2 protein was also significantly correlated to pathologic grades、embolus、capsules and HBsAg of the tumors.
3 the expression of AKT2 in 4 cell lines were studied by Western-blot method.4 cell lines were all expressed,especially SMMC-7721.We find AKT2 are expressed in cytoplasm and cytomembrane mainly.It suggested that the AKT2 gene play an important role in the malignant progression of cancers.The overexpression of AKT2 and the correlation between AKT2 expression and tumor grade provided a useful parameter for evaluating the degree of malignancy at molecular level and for selecting the target gene in gene therapy.
PartⅡstudy on designing siRNA of blocking AKT2 expression,construction expression vector and optimizing transfection conditions
In studying siRNA of mammal cells,there are two key steps.One is to select effctive sequence of siRNA,the other is to transfer the sequences into cells effectively.We design the sequence in network.
1 there is interaction between Liposome2000 quantity and plasmid quantity in transfection.There is highest efficiency when Lipofectamine2000 volume is 10ul and the palsmid of quantity is 4ug.The efficiency is over 85%. Transfection time is longer,cell cytotoxicity is bigger.The best time is 8 hours after transfection,the biggest transfection,the biggest transfection efficiency and the lest cell cytotoxicity.
2 In the siRNA experiment we find the AKT2mRNA is lowest on the thirdth day by RT-PCR,but the AKT2 mRNA is not marked changed in the control teams.
We also find the AKT2 protein is lowest on the fourth day by Western-blot but the AKT2 protein is not marked changed in the control teams.The plasmid, Supersilencing- AKT2–siRNA is more,AKT2 protein is lowest.We can draw the conclusion:the plasmid can be transferred into SMMC7721 cell efficiently and AKT2mRNA or AKT2 ptotein is induced.
PartⅢThe inhibitory effect of AKT2-siRNA on the growth of HCC cells in vitro
Because there was no effective treatments on liver cancers,it is very urgent and important to find out new methods to solve this problem.According to the results in part I,we believed that AKT2 gene be a target in gene therapy of cancers.So we planed to utilize small interfere RNA technique to observe the inhibitory effects of small interfere RNA AKT2 mRNA on the expression of AKT2.
1 We confirmed a/the overexpression of AKT2 in 7721 HCC cells by RT-PCR analysis and immunohistochemistry.We use 7721 HCC cells to Stable cell line which has plasmid Supersilencing-AKT2-siRNA or Supersilencing–AKT2-GFP growth rate among these groups had differences detected by MTT assay.
2 The cell cycle is analysizd by FCM assay.The S stage of experimental team is longer than control team(P<0.05)but G0/G1 stage is shorter.The expression of CyclinD1、P27、P21 are reduced magnificently in experimental team by western-blot analysis.
3 In adhesion experiment we find the adhesion capability of SMMC7721-siRNA cell is decreased 3 times or so.SMMC7721-siRNA cell invasion is decreased by Scribing test and Transwell test.blocking AKT2 also reduced the decreasing of expression of MMP-2、MMP-9.we find the expression of LNR and ICAM-Ⅰare inhibited marked in SMMC7721-siRNA cell line. but E-cadherin is increased markedly.
We can draw the conclusion:blocking of AKT2 expression can inhibit growth and metastasis of SMMC7721-siRNA cell line.
PartⅣstudy on blocking AKT2 protein expression to promote SMMMC7721 Apoptosis
AKT2 is related to tumor Apoptosis closely.In order to study the value of AKT2 in gene theraphy,we observe the relationship between AKT2 and chemotherapeutics.
Induction Apoptosis by CHX,we can see Apoptosis cell is increased in SMMC7721-siRNA cell line.By DAPI analysis,the Apoptosis rate is decreased markedly in in SMMC7721-siRNA cell line.(P<0.05)
1 SMMC7721-AKT2-siRNA cell line processed with CHX for 24 hour,we find the apoptotic index (34.2%)is higher than control team(16.7%,20.4%).(P<0.05) by FCM.Outcome make it clear that blocking AKT2 can inhibit cell growth and enhance it sensitivity to chemotherapeutics.
2 Processed with CHX,we find the protein Bax,Caspase3 of SMMC7721- AKT2-siRNA cell lines up-regulated(P<0.05),meanwhile Bcl-2 is downregulated by western-blot.
3 Using equidensity chemotherapeutics Gem,we see growth inhibiting of SMMC7721-AKT2-siRNA cell line is higher than control team.(P<0.05). From above,we know blocking AKT2 can increase apoptositic sensitivity of hepatoma carcinoma cell to chemotherapeutics.This is foundation to the next in vivo experiment. PartⅤThe therapeutic effect of AKT2 small interfere RNA for HCC 7721 cells in vivo
In order to make further investigation on the role of AKT2 gene in the development of liver cancer and the effect of siRNA gene therapy in vivo,we carried out vivo study with BALB/nu/nu nude mice.15 nude mice were randomly divided into three groups and three prepared cells were subcutaneously injected on the back of mice:(1)control group:10 mice injected with wild-type 7721 HCC cells;(2) positive control group:5 mice injected with 7721 HCC cells transfected with plasmid GFP (3)experimental group:5 mice injected with 7721 HCC cells transfected with AKT2 small interfere RNA.The results showed:the transfected group were significently lower than that of positive control group and control group in volume、growth rate of tumors.In the tumors of experimental group, we knew that AKT2 protein were effectively blocked through analysis of wetern-blot.
The present study demonstrated that AKT2 play an important role in the angiogenesis and development of HCC,clarified the therapeutic effect of AKT2 siRNA in vivo and suggested that AKT2 gene be a target for small interfere RNA gene therapy of liver cancer.We get a useful theory basis for gene therapy of liver cance
引文
1. Tsuzuki T,Sugioka A,Ueda M.Hepatic resection for hepatoce Uular carcinoma[J].Surgery,1990,107:511.
2. Paquet K-J,Koussouris P,1VErcado MA,et al.Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma:a prospective study[J].Br J Surgrey,1991,78:459.
3. France D,Capussotti L,Smadja C,et al.Resection of hepatocellular carcinoma:results in 72 European patients with cirrhosia[J].Gastroenterrology,1990,98:733.
4. Pham NA, Tsao MS, Cao P et al. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pancreas. 2007 Oct;35(3):e16-26
5. Liang J,Zubovitz J, Petrocelli T et al. PKB/Akt phosphorylates p27,impairs nuclear import of p27 and opposes p27-mediated G1 arrest.Nat Med.2002;8:1153-1160
6. Fujita N,Sato S,Katayama K et al.Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.J Biol Chem.2002 ;277:28706-28713
7. Li Y, Dowbenko D,Lasky LA.AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem. 2002; 277:11352-11361
8. Medema RH,Kops GJ,Bos JL,et a1.AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kipl[J].Nature,2000,404 (6779):782-787.
9. Gagnon V.St-Germain ME,Parent S,et a1.Akt activity in endometrial cancer cells:regulation of cell survival through cIAP-1[J].Int J Oncol,2003,23(3):803-810.
10. Dan HC,Sun M ,Kaneko S,et a1.Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein(XIAP)[J].J Biol Chem,2004,279(7):5405-5412.
11. Yeatman TJ,Nicolson GL.Molecular basis of tumor progression:mechanisms of organ-specific tumor metastasis[J].Semin Surg Oncol,1993,9(3):256-263.
12. Bermont L,Lamielle F,Fauconnet S,et aL Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma ceils[J].lnt J Cancer,2000,85(1):117-123.
13. Fire A,et al.Potent and specific genetic interference by double-stranded RNA in Gaenorhabditis elegans.Nature,1998,391:806.
1. Colleoni M Gaion F,Liessi C;et al.Medical treatment of hepatocellular carcinoma any progress? Tumri 1994;80:315-26。
2.苗立君,王静.AKT与肿瘤的研究进展[J]国外医学.生理、病理科学与临床分册,2004,24(5):406-409.
3. Vivanco I, Sawyer CL. The phosphatidylinositol-3kinose-AKT pathway in human cancer [J]. Nat Rev,2002,2:489-501
4. ARBOI EDA M J,LYONS J F,KABBINAVAR FF,et a1. 0verexpression of AKT2/protein kinase Bbeta leads to up regulation of beta1 integrins, increased invasion,and metastasis of human breast andovarian cancer cells[J].Cancer Res,2003,63:196—206.
5. CHENG J Q,RUGGERI B,KLEIN W M,et a1.Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA[J].Proc Natl Acad Sci USA,1996,93:3636—3641.
6. ROSSIG L,JADIDI A S,URBICH C,et a1.Akt dependent phosphory1ation of p2 1(Cip1) regulates PCNA binding and proliferation of endothelial cells[J].M ol Cell Biol,2001,21:5644—5657.
7.杨鹏,王春友,牛彦锋,等.AKT2在胰腺癌组织中的表达及意义[J].山东医药,2006,46(12):13-14.
8.苗丽君,王静,孙振涛,等.癌基因AKT2在肺鳞状细胞癌和腺癌中的表达及与细胞增殖转移的关系[J].中国肿瘤临床,2006,33(23):1325-1328.
9. RUHUL AMIN A R , SENGA T , OO M L , et a1 . Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine,IL-1 beta:a role for the dual signalling pathways,Akt and Erk[J]. Genes Cells,2003,8:515-523.
10. Arboleda M J,Lyons J F,Kabbinavar F F,et a1.Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of betal integrins,increased invasion,and metastasis of human breast and ovarian cancer cells[J].Cancer Res,2003,63(1):196-206.
1. Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391(6 669):806-811
2. Yu J Y,De Ruiter SL,Turner DL.RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[J].Proc Natl Acad Sci U S A,2002,99(9):6 047-6 052
3. Yang D,Buchholz F,Huang Z,et al.Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells[J]Proc Natl Acad Sci U S A,2002,99(15):9 942-9 947
4. Castanotto D,Li H,Rossi JJ.Functional siRNA expression from transfected PCR products[J].RNA,2002,8(11):1 454
5. Sui G,Soohoo C,Affarel B,et a1.A DNA vector based RNAi,technology to suppress gene expression in mammalian cells[J].Proc Natl Acad Sci U S A,2002,99(8):5 515-5 520。
6. Paddison PJ,Caudy AA,Hannon GJ.Stable suppression of gene expression by SiRNA in mammalian cells.Proc Natl Acad Sci U S A 2002;99(3):1443-8
7. Yang SH,Tutton S,Yoon K.Specific Double-Stranded RNA Interference in Undifferentiated Mouse Embryonic Stem Cells.Molecular and Cellular Biology.2001; 21:7807-7816
8. Xia HB,Mao QW,Paulson HL,Davidson BL.SiRNA mediated gene silencing in vitro and in vivo.Nat Biotechnol 2002;20:1006-1010
1. Wang D,Jing N,Lin Q.Stearylamine liposome as a new efficient reagent fox DNA transfection of eukaryotic cells.Biochem Biophy Res Co m mu,1996,226(2):450-455
2. Jaaskelainen 1,M onkkonen J,U rttiA.Oligonucleotide cationicliposome interaction.A physicochem ical study[J]Biochim Biaphus Acta,1994,1195(l):115-123。
3. Stamatutos L et al.Interactions of cationic lipid vesicles with negatively charged phosphollpld vesicles and biology membranes[J]Biochemistry,1 988,27:3917-3925
4. Fashnan SJ,Tousigant JD,I Aason M1,et al.Optimivation of fonnulatians and conditions for the aerosol delivery of functional cationic lipid:DNA cotnlexes.Hum Gene ner,1997;8:313-322
5. Felgner PL.Improvements in cationic liposomes for in vivo gene transfer.Hum Gene'Iher,1996;7:1791-1793
6. Weber M,M oller K,W elzeck M,et al.Short technical reports Effects of lip opolysaccharide on transfection efficiency in eukaryotic cells[J].B iotechniques,1995, 19(6):930-940.
7. Mac Gregor G.Optimizxing of electroporation using reporter genes.In Chang DC·Chassy BM·Saunders JAand Sowers AE(Eds).Academic Press Guide to Electroporation and Electrofusion. Academic Press.San Diego.1992.P.465-470.
8. Chalfie M,Tu Y,Euskirchen G,et al.Green fluorescent protein as a marker fox gene expression[J]. Science,1994,263:802-805
1. Fire A,Xu S,Montgomery Mc et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans,Nature,1998,391:806-811.
2. NICHOLDNR H,NICHOLDN A W.Molecular characterization Of a mouse cDNA encoding Dicer,a ribonucleaseⅢortholog involved in RNA interference[J].Mann Genome,2002,13(2);67-73.
3. ELBASHIR S M,HARBORTH J,WEBER K,et a1.Analysis Of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,(26),199-213
4. SABINE B.Antisense 2 RNA regulation and RNA interference[J].Biochemica et Biophysica Acta, 2002,1575:15-25.
5. SUI G,SOOHOO C,AFFAIR E B,et al.A DNA vector2 based RNAi technology to suppress gene expression in mammalian cells[J].Genetics,2002,99(8),5515--5520.
6. ELBASHIR S M,HARBORTH J,WEBER K,et a1.Analysis Of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,(26),199-213
7. SlJEN T,FLEENOR J,SIMMER F,et al.On the role of RNA Amplification in dsRNA2 triggered gene silencing[J].Cell,2001,107(4),465-476.
8. LIPARDI C,WEI Q,PATERSON B M.RNAi.as random degradative PCR:siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNA[J]. Cell,2001,107(3):297--307.
9. Ngo H,Tschudi C,Gull K,et al.Double 2 stranded RNA induces mRNA degradation in Trypanosoma brucci.Proc Natl Acad Sci USA,1998,95(25):14687-14692.
10. Montgomery MK,Xu S,Fire A.RNA as a target of double stranded RNA mediated genetic interference in Caeanorhabditis elegans.Proc Natl Aced Sci USA,1998, 95(25): 15502--15507.
11. Har Dorth J,Elbashir SM,Bechert K,et al.Identification of essential genes in cultured mammalian cells using small interferingRNAs.J Cell Sci,2001,114:4557--4565.
12. Yang D,Lu H,Erickson JW,Evidence that processed small dsRNAs may mediate sequence2specific mRNA degradation duringRNAi in Drosophila embryos.Curr Biol,2000,10(19):1191--1200.
13. Sabine B.Antisense RNA regulation and RNA interference.Biochem Biophys Acta,2002,1575 (123):15225.
14. Gan L,Anton KE,Masterson BA,et al.Specific interference with gene expression and gene function mediated by long double stranded RNA in neural cells.J,2000, 9(18):1198--1208.
1. Pham NA, Tsao MS, Cao P et al. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pancreas. 2007 Oct;35(3):e16-26
2. Hanada M et al.Biochim Biophys Acta,2004。1697(1-2):3-16
3. Tokuda E, Fujita N, Oh-hara T et al. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein,down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res. 2007, Oct 15;67(20):9666-9676
4. Brownawell AM,Kops GJ, Macara IG et al. Inhibition of nuclear import by protein kinase B(Akt)regulates the subcellular distribution and activity of the forkhead transcription factot AFX.Mol Cell Biol. 2001;21:3534-3546
5. Liang J,Zubovitz J, Petrocelli T et al. PKB/Akt phosphorylates p27,impairs nuclear import of p27 and opposes p27-mediated G1 arrest.Nat Med.2002;8:1153-1160
6. Fujita N,Sato S,Katayama K et al.Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.J Biol Chem.2002 ;277:28706-28713
7. Li Y, Dowbenko D,Lasky LA.AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem.2002;277:11352-11361
8. Skeen JE, Bhaskar PT, Chen CC et al. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell. 2006 Oct;10(4):269-80
9. Gao N,Flynn DC,Zhang Z,et a1.The G1 cell cycle progression and the expression of Gl cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells[J].Am JPhysiol Cell Physiol,2004,287(127):C281-C291.
10. ShioiT,McMullenJR,KangPM,et al.Akt/protein kinaseB promotes organ growth in transgenic mice.Mol Cell Biol.2002,22(8):2799-2809
11. Faridi J,Fawcett J,Wang L,et al.Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation.Am J Physiol Endocrinol Metab.2003,285(5):E964-972
12. Reif S,Lang A,Lindquist JN,et al.The role focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type l collagen expression. J Biol Chem.2003,278(10):8083-8090
13. Jetzt A,Howe JA,Horn MT,et al.Adenoviralmediated expression of a kinase dead mutant of Akt induces apoptosis selectively intum or cells and suppresses tumor growth in mice [J].Cancer Res,2003,63(20):6697-706.
14. Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation Ericson K, Gan C, Cheong I, Rago C, Samuels Y, Velculescu VE, Kinzler KW, Huso DL, Vogelstein B, Papadopoulos N.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2598-603. Epub 2010 Jan 20.
15. Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. Kirkegaard T, Witton CJ, Edwards J, Nielsen KV, Jensen LB, Campbell FM, Cooke TG, Bartlett JM. Histopathology. 2010 Jan;56(2):203-11
16. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Fortin SP, Ennis MJ, Savitch BA, Carpentieri D, McDonough WS, Winkles JA, Loftus JC, Kingsley C, Hostetter G, Tran NL.Mol Cancer Res. 2009 Nov;7(11):1871-81. Epub 2009 Oct 27
17. Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.Al-Saad S, Donnem T, Al-Shibli K, Persson M, Bremnes RM, Busund LT.Anticancer Res. 2009 Oct;29(10):4175-83
18. The expression of oncogene AKT2 in laryngeal squamous cell carcinoma and its clinical significance]Chen Y, He Y, Zhang S, Li L, Zhu X, Liu Y.Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Jun;23(12):539-41, 545. Chinese
19. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma. Iamaroon A, Krisanaprakornkit S. Oral Oncol. 2009 Oct;45(10):e175-9. Epub 2009 Jul 22
20. Medema RH,Kops GJ,Bos JL,et a1.AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kipl[J].Nature,2000,404 (6779):782-787.
21. Gagnon V.St-Germain ME,Parent S,et a1.Akt activity in endometrial cancer cells:regulation of cell survival through cIAP-1[J].Int J Oncol,2003,23(3):803-810.
22. Dan HC,Sun M ,Kaneko S,et a1.Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein(XIAP)[J].J Biol Chem,2004,279(7):5405-5412.
23. Alberts B,et al.Molecular Biology of the Cell.4th ed.New York&London:Carland Publishing Inc, 2002
1. Yeatman TJ,Nicolson GL.Molecular basis of tumor progression:mechanisms of organ-specific tumor metastasis[J].Semin Surg Oncol,1993,9(3):256-263.
2. Aznavoorian S,Murphy AN,Stetler-stevenson WG,et al.Molecular aspects of tumor cell invasion and metastasis[J].Cancer,1993,71(4):1368
3. Kim D,Kim S,Koh H,et al.Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production[J].FASEB J,200l,15(11):1953-1962
4. Yamamoto Y,Tsutsumi Y,Mayumi T.Molecular design of bioconljugated cell adhesion peptide with a water soluble polymeric modifier for enhancement of an time tastatic effect[J].Curr Drug Targets,2002,3(2):123
5. A rihro K,InaiK,Kurara K.Distribution of laminin,typeⅣcollagen and fibronectin in the invasive component of breast carcinoma.Acta Pathol Jpn Dec,1993;43:758
6. Kibbey MC,Grant DS,Kleinman HK.Role of file SIKVAV site of laminin in plarmfion of angiogenesis and tumor growth:All in vivo Matfigel model[J].J Natl CancerInst(Bethesda), 1992;84:1633-1638.
7. DeRoock B,Pemfington ME,Stuka TC,et al.Synthetic pepfdes inhibit adhesion of human tumor cells to extracellular matrix proteins[J].Cancer Res,2001;61(8): 3308-3313.
8. Carlod PS,Norman HA,Parmender P,et al.Prostate cancer progression,metastasis,and gene expression in transgenis mice.Cancer Res,1 997,57:900-907.
9. Hee J,Sook B,Ho Y,et al.Anti-invasive activity of solie and correlates with the reduced expression of matrix met all op rote ninnase-9(MMP-9)in HT-1080 human fibrosarcoma cells.Cancer Res, 1996,56:2281-2285.
10. Allgayer H,Babic K,Beyer BC,et al.Prognostic relevance of MMP-2(72kDconagenase IV)in gastric cancer[J].Oncology,1998,55(2):152.
11. Aznavoorian S,Murphy AN,Stetler Stevenson WG,et al.Molecelular suspects of tumor cell invasion and metastasis[J].Cancer,1993,71:1368
12. Dunn SE,Torres JV,Oh JS,et al.Up-regulation of urokinase type plasminogen activator by insulin-like growth factor-I depends upon phosphatidytinositol-3 kinase and mitogen-activated protein kinase[J].Cancer Res,2001,61(4):1367-1374.
13. Fujihara T,Sawada R,Hirskawa K,et al.Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis.Clin Exp Metastasis,1998,16:389-398
14. Yoong KF,Me Nab G,Hubscher SG.Vascular adhesion protein and ICAM-1 support the adhesion of tumor in filtrating lymphocytes to tumor endothelium in human hepatocellular carcinoma.J I m munol,1998,160:3978-3988
15. Albelda S M,Buck CA.Integrins and other cell adhesion molecules.FASEB J,1996,17:71-81
16. Liotta LA,Wewer U,Rao NC et al.Bio chemical mechanisms of to more invasion and metastases. Adv Exp Med Biol,1988,233:161
17. Pellegrinl R,Martignone S,Tagliabue E et al.Prognostic significance of laminin production in relation with its receptor expression in human breast carcinoma.BreastCancer Res Treat,1995,35:195
18. Marques LA,Franco ELF,Torloni H et al.Independent prognostic value of laminin receptor expression in breast cancer survival.Cancer Res,1990,50:1 870
19. MareelM , B racke M&VanRoy F.Cancer metastasis:negative regulation by an invasion-suppressor complex.Cancer Detect P rev,1995,19(5):451.
20. Dunn SE,Ehrlich M,Sharp NJ,et al.A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion,invasion,and metastasis of breast cancer[J].Cancer Res,1998,58(15):3353-3361.
1. Nam SY,Jung GA,Hur GC,et a1.Upregulation of FLIP(S) by Akt,a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers[J]. Cancer Sci,2003,94(12):1066-1073.
2. Bommhardt U et a1.J Immunol,2004,172(12):7583-7591
3. Inayat-Hussain,Couet SHC,Cohen GM,et al.Processing/activation of CPP32-1ike proteases is involved in transforming growth factor is induced apoptosis in rat hepatocytes.Hepatology 1997;25:1516-1523.
4. Ekert PG,Silke J,Vaux DL.Caspas-3 inhibitors.Cell Death Differ 1999;6:1081-1086.
5. Patel T,Gores G.Apoptosis and hepatobiliary disease Hepatology,1995,21:1725-1741
6. Ledda Columbano GM,Coni P,Curto M,et al.Induction of two different modes of cell death,apoptosis and necrosis,in rat liver after a single dose of thioacetamide.Am J Patho1,1991,139(5):1099-1109
7. Laddar Columbano GM,Coni P,Faa G,et a1.Rapid induction of apoptosis in rat liver by cycloheximide.Am J Patho1,1992,140(3):545-549.
8. Kimura K,Yamamoto M.Modification of the alternative splicing process of testosterone-repressed prostate message-2(TRPM2)gene by protein synthesis inhibitors and heat shock treatment.Biochim Biophys Acta,1996,1307(1):83-88
9. Esolen L M,Sukw P,Jm arle H,et al.Apoptosis as a cause of death in meases virus-infected cells.J Virology,1995,169(6):3955-3958
10. DeZhong L,YouXin J,Hua FI,et al,Preparation and identification of activity ofanti-HPV-6b/l 1E 1 universal ribozyme-Rzl 198 in vitro.Asian Journal of Andrology 1999;1:195-201.
11. Uhlenbeck OC.A small catalytic oligoribonucleotide.Nature 1987;328:569-600.
12. Teodoro JG,Branton PE.Regulation of apoptosis by viral gene products.J Virol,1997,71:1739-1746.
13. Phylaetou LA,Kilpatrick Mw,Wood MI.Ribozyraes as therapeutic tools for genetic disease.Hum Mol Genet,1998;7(10):1649-1653.
14. O rter A O and Janicke R U.Emerging roles of easpase-3 in apoptosis.Cell Death Differ,1999,6:99-104
15. Y.Du,R.C.Dodei,K.R.Bales,R.Jemmerson,E.Hamilton-Byrd,and S.M.Involvement of a caspase-3-1ike cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons,J.Neurochem 69(1997)1382-1388.
16. R.Klara,Birikh,A.Paul,HEATON and E.Fritz,The structure,function and application of the hammerhead ribozyme,Eur.J.Biochem.245(1997)1-16.
17. K.Kuida,T.S.Zheng,S.Na,CY.Kuan,D.Yang,H.Karasuyama,P.Rakie and R.A.Flavell, Decreased apoptosis in the brain and premature lethality in CPP32-dcficient mice,Nature 384(1996) 368-372.
18. S.A.Loddick,A.MacKenzie,and N.J.RothwcU,An ICE inhibitor,z-CAD-DCB attenuates ischaemic brain damage in the rat,Neuroreport.9(1996)1465-1468.
19. S.J.Martin,D.R.Green,Protease activation during apoptosis:death by a thousand cuts7 Cell 82 (1995)349-352.
20. J.C.Martinou and R.Sadoa,ICE-like proteases execute the neuronal death program,Curr.Opin. Neurobiol.6(1996)609-614.
21. J.C.Mayo,R.M.Sainz,I.Antolin,C.Rodriguez,Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage,Brain Res.818(1999)221-227.
22. N.J.McCarthy,L.L.Rubin,and K.L.Philpott,Involvement of caspases in sympathetic neuron apoptosis,J.Cell Sci.l 10(1997)2165-2173.
23. Reed JC.Double identity fox proteins of the Bcl-2 family.Nature,1 997,387:773-776
24. Leung LK,Wang TT.Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway inhuman breast cancer cell line MCF Breast Cancer Res Treat,1999,55:73-83
25. Gibson LF,Fortney J,Magro G,et al.Regulation of Bax and Bcl-2 expression in breast cancer cells by chemotherapy.Breast Cancer Res Treat,1999,55:107-117
26. Nakata B,Muguru ma K,Hirakawa K,et al.Predictive value of Bcl-2 and Bax protein expression for the motherapeutic effect in gastric cancer.On cology,1998,55:543-547
1.刘平,赵志泉,张小勇等。人胃癌组织块裸鼠原位移植/转移模型的建立。肿瘤防治与研究,2001:28:15-16。
2. FerraraN,Chen H,Davis-SmythT,et a1.Vascular endothelial growth factor is essential for corpus luteum angiogenesis[J].Nat Med,1998,4(3):336-340.
3. Bmstmann H,Naude S.Vascular endothelial growth factor expression in serellS ovarian carcinoma : relationship with high mitotic activity and hish FIGO stage(J].cynec0l Oneol,2002,84(1):47-52.
4. Arboleda MJ, Lyons JF, Kabbinavar FF, et al. Overexpression of AKT2/protein kinase Bh leads to upregulation of h1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 2003;63:196–206.
5. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007;67:1979–87.
6. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 2005;20:539–50.
7. Irie HY, Pearline RV, Grueneberg D, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005;171: 1023–34.
8. Fortin SP, Ennis MJ, Savitch BA, Carpentieri D, McDonough WS, Winkles JA, Loftus JC, Kingsley C, Hostetter G, Tran NL. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Mol Cancer Res. 2009 Nov;7(11):1871-81.
1. Pham NA, Tsao MS, Cao P et al. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pancreas. 2007 Oct;35(3):e16-26
2. Hanada M et al.Biochim Biophys Acta,2004。1697(1-2):3-16
3. Tokuda E, Fujita N, Oh-hara T et al. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein,down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res. 2007, Oct 15;67(20):9666-9676
4. Brownawell AM,Kops GJ, Macara IG et al. Inhibition of nuclear import by protein kinase B(Akt)regulates the subcellular distribution and activity of the forkhead transcription factot AFX.Mol Cell Biol. 2001;21:3534-3546
5. Liang J,Zubovitz J, Petrocelli T et al. PKB/Akt phosphorylates p27,impairs nuclear import of p27 and opposes p27-mediated G1 arrest.Nat Med.2002;8:1153-1160
6. Fujita N,Sato S,Katayama K et al.Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.J Biol Chem.2002 ;277:28706-28713
7. Li Y, Dowbenko D,Lasky LA.AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem. 2002; 277:11352-11361
8. Skeen JE, Bhaskar PT, Chen CC et al. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell. 2006 Oct;10(4):269-80
9. Gao N,Flynn DC,Zhang Z,et a1.The G1 cell cycle progression and the expression of Gl cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells[J].Am JPhysiol Cell Physiol,2004,287(127):C281-C291.
10. ShioiT,McMullenJR,KangPM,et al.Akt/protein kinaseB promotes organ growth in transgenic mice.Mol Cell Biol.2002,22(8):2799-2809
11. Faridi J,Fawcett J,Wang L,et al.Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation.Am J Physiol Endocrinol Metab.2003,285(5):E964-972
12. Reif S,Lang A,Lindquist JN,et al.The role focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type l collagen expression. J Biol Chem.2003,278(10):8083-8090
13. Jetzt A,Howe JA,Horn MT,et al.Adenoviralmediated expression of a kinase dead mutant of Akt induces apoptosis selectively intum or cells and suppresses tumor growth in mice [J].Cancer Res,2003,63(20):6697-706.
14. Maeda H et a1.Transplant Proc,2004,36(4):l163-1165
15. West KA,Brognard J,Clark AS,et a1.Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells[J].J Clin Invest,2003,111(1):81-90.
16. Nam SY,Jung GA,Hur GC,et a1.Upregulation of FLIP(S) by Akt,a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers[J]. Cancer Sci,2003,94(12):1066-1073.
17. Bommhardt U et a1.J Immunol,2004,172(12):7583-7591
18. Medema RH,Kops GJ,Bos JL,et a1.AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kipl[J].Nature,2000,404 (6779):782-787.
19. Gagnon V.St-Germain ME,Parent S,et a1.Akt activity in endometrial cancer cells:regulation of cell survival through cIAP-1[J].Int J Oncol,2003,23(3):803-810.
20. Dan HC,Sun M ,Kaneko S,et a1.Akt Phosphorylation and Stabilization of X-linkedInhibitor of Apoptosis Protein(XIAP)[J].J Biol Chem,2004,279(7):5405-5412.
21. Zhou X,Tna M,Stone Hawthorne V,et a1.Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 over expression predicts tumor progression in breast cancers.Clin Cancer Res,2004,10(20):6779-678 8
22. Dimmeler S,Zeiher AM.Akt takes center stage in angiogenesis signaling.Circ Res,2000,86(1):4-5.
23. Healh D,Skinner, Jenny ,et al.Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-inducible Factor 1α,HDM2,and P70S6Kl in Response to Phosphatidylinositol 3-kinase/AKT Signaling.J Biol Chem,2004,279(44):45643-45651
24. Zhong XS,Zheng JZ,Reed E,et al,SU5416 inhibited VEGF and HIF-1 expression through the PI3K/PKB/P70s6kl signaling Pathway Biochernical and Biophysical Research.Communications,2004,324:471-480
25. Gao N,Nester RA,Sarkar MA,et al.4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor lalpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/AKT/FRAP pathway in OVCAR-3 and A2780-CP70 hunman ovarian carcinoma cells.Toxicol Appl Pharmacol,2004,196(1):124-135
26. ZHONG H,CHILES K,FELDSER D,et a1.Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/Akt/FRAP pathway in human prostate cancer cells:implications for tumor angiogenesis and therapeutics[J].Cancer Res,2000,60(6):1541-1545
27. Nakashio A,Fujita N,Tsuruo T.Topotecan inhibits VEGF-and bFGF-induced vascular endothelial cell migration via down regulation of the PI3K-Akt signaling pathway[J]. Int J Cancer,2002,98(1):3641
28. Matei D,Kelich S,Cao L,et a1.PDGF BB induces VEGF secretion in ovarian cancer[J].Cancer Biol Ther,2007,6(12):1951-9
29. Cao Z , Liu LZ , Dixon DA , et a1 . Insulin-like growth factor-I inducesCyclooxygenase-2 expression via P13K,MAPK and PKC signaling pathways in human ovarian cancer cells[J].Cell Signal,2007,19(7):1542-53
30. Larue L,Bellacosa A,Epithelial-mesenchymlal transition in development and cancer: role of phosphatidylionsitol 3-kinase/AKT pathways.Oncogene, 2005, 24(50): 7443- 7454
31. CINDY YF,JEFFERY JW,KYMBERLEY LS,et al.Inhibition of integrin-linked kinase by a selective small molecule inhibitor,QLT0254,inhibits the PI3K/PKB/mTOR . STAT3,and FKHR pathways and tumor growth , and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts[J].Cancer Res,2005,65(4):1497-1504.
32. KIM MS,PARK MJ,MOON EJ,et a1.Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells[J].Cancer Res,2005,65(3):686-691
33. Kim CS,Vasko VV,Kato Y,et al.AKT activation promotes metastasis in a mouse model offollicular thyroid carcinoma [J ].Endocrinology,2005,146(6):4456-4463.
34. Kim D,Kim S,Koh H,et al.Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production[J].FASEB J,200l,15(11):1953-1962
35. Zhang D,Brodt P.Type l insulin-llke growth factor regulates MTl-MMP synthesis and tumor invasion via PI3-kinase/Akt signaling[J].Oncogene,2003,22(7):974-982
36. Tanno S,Tanno S,Mitsuuchi Y,et al.AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasivenessof human pancreatic cancer cells[J].Cancer Res,2001,61(2):589-593
37. Hill MM,Hemmings BA. Inhibition of protein kinase B/AKT implications for cancer therapy[J].Pharmacol Ther,2002,93(3):243-251.
38. Nakanishi K , Sakamoto M , Yasuda J , et a1 . Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer[J].Cancer Res,2002,62(10):2971-2975
39. BONDAR VM,SWEENEY-GOTSCH B,ANDREEFF M,et a1.Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo[J].Mol Cancer Ther,2002,l(12):989-997.
40. TAN J,HALLAHAN D E.Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response[J].Cancer Res,2003,63(22):7663-7667
41. CLARK A S,WEST K,STREICHER S,et al.Constitutive and inducible Akt activity promotes resistance to chemotherapy,trastuzumab,or tamoxifen in breast cancer cells[J].Mol Cancer Ther,2002,1(9):707-717.
42. SHINGU T,YAMADA K,HARA N, et a1.Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells[J].Cancer Res,2003,63(14):4044-4047.
43. West KA,Brognard J,Clark AS,et a1.Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells[J].J Clin Invest,2003,111(1):81-90.
44. GUPTA AK,BAKANAUSKAS VJ,CERNIGLIA GJ,et a1.The Ras radiation resistance pathway[J].Cancer Res,2001,6l(10):4278-4282.
45. SAKUNTALA W G,JULIE L,ELISABETH B,et a1.The insulin-like growth factor-I receptor kinase inhibitor,NVP-ADW742,sensitizes small cell lung cancer cell lines to the effects of chemotherapy[J].Clin Cancer Res,2005,11(15):1563-1571
46. Larson SD, Jackson LN, Riall TS et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg. 2007 May;204(5):764-773; discussion 773-775. Epub 2007 Feb
47. An HJ, Cho NH, Yang HS, et al. Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells. J Pathol. 2007 Jun;212(2):161-169.
48. Cheng GZ, Chan J, Wang Q et al. Twist transcriptionally up-regulates AKT2 in breastcancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res. 2007 Mar 1;67(5):1979-1987.
49. Zhang M, Fang X, Liu H et al. Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chloro-2-methylellipticinium acetate (CMEP). Biochem Pharmacol. 2007 Jan 1;73(1):15-24. Epub 2006 Sep
50. Maroulakou IG, Oemler W, Naber SP,et al. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 2007 Jan 1;67(1):167-177
2. Paquet K-J,Koussouris P,1VErcado MA,et al.Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma:a prospective study[J].Br J Surgrey,1991,78:459.
3. France D,Capussotti L,Smadja C,et al.Resection of hepatocellular carcinoma:results in 72 European patients with cirrhosia[J].Gastroenterrology,1990,98:733.
4. Pham NA, Tsao MS, Cao P et al. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pancreas. 2007 Oct;35(3):e16-26
5. Liang J,Zubovitz J, Petrocelli T et al. PKB/Akt phosphorylates p27,impairs nuclear import of p27 and opposes p27-mediated G1 arrest.Nat Med.2002;8:1153-1160
6. Fujita N,Sato S,Katayama K et al.Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.J Biol Chem.2002 ;277:28706-28713
7. Li Y, Dowbenko D,Lasky LA.AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem. 2002; 277:11352-11361
8. Medema RH,Kops GJ,Bos JL,et a1.AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kipl[J].Nature,2000,404 (6779):782-787.
9. Gagnon V.St-Germain ME,Parent S,et a1.Akt activity in endometrial cancer cells:regulation of cell survival through cIAP-1[J].Int J Oncol,2003,23(3):803-810.
10. Dan HC,Sun M ,Kaneko S,et a1.Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein(XIAP)[J].J Biol Chem,2004,279(7):5405-5412.
11. Yeatman TJ,Nicolson GL.Molecular basis of tumor progression:mechanisms of organ-specific tumor metastasis[J].Semin Surg Oncol,1993,9(3):256-263.
12. Bermont L,Lamielle F,Fauconnet S,et aL Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma ceils[J].lnt J Cancer,2000,85(1):117-123.
13. Fire A,et al.Potent and specific genetic interference by double-stranded RNA in Gaenorhabditis elegans.Nature,1998,391:806.
1. Colleoni M Gaion F,Liessi C;et al.Medical treatment of hepatocellular carcinoma any progress? Tumri 1994;80:315-26。
2.苗立君,王静.AKT与肿瘤的研究进展[J]国外医学.生理、病理科学与临床分册,2004,24(5):406-409.
3. Vivanco I, Sawyer CL. The phosphatidylinositol-3kinose-AKT pathway in human cancer [J]. Nat Rev,2002,2:489-501
4. ARBOI EDA M J,LYONS J F,KABBINAVAR FF,et a1. 0verexpression of AKT2/protein kinase Bbeta leads to up regulation of beta1 integrins, increased invasion,and metastasis of human breast andovarian cancer cells[J].Cancer Res,2003,63:196—206.
5. CHENG J Q,RUGGERI B,KLEIN W M,et a1.Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA[J].Proc Natl Acad Sci USA,1996,93:3636—3641.
6. ROSSIG L,JADIDI A S,URBICH C,et a1.Akt dependent phosphory1ation of p2 1(Cip1) regulates PCNA binding and proliferation of endothelial cells[J].M ol Cell Biol,2001,21:5644—5657.
7.杨鹏,王春友,牛彦锋,等.AKT2在胰腺癌组织中的表达及意义[J].山东医药,2006,46(12):13-14.
8.苗丽君,王静,孙振涛,等.癌基因AKT2在肺鳞状细胞癌和腺癌中的表达及与细胞增殖转移的关系[J].中国肿瘤临床,2006,33(23):1325-1328.
9. RUHUL AMIN A R , SENGA T , OO M L , et a1 . Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine,IL-1 beta:a role for the dual signalling pathways,Akt and Erk[J]. Genes Cells,2003,8:515-523.
10. Arboleda M J,Lyons J F,Kabbinavar F F,et a1.Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of betal integrins,increased invasion,and metastasis of human breast and ovarian cancer cells[J].Cancer Res,2003,63(1):196-206.
1. Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391(6 669):806-811
2. Yu J Y,De Ruiter SL,Turner DL.RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[J].Proc Natl Acad Sci U S A,2002,99(9):6 047-6 052
3. Yang D,Buchholz F,Huang Z,et al.Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells[J]Proc Natl Acad Sci U S A,2002,99(15):9 942-9 947
4. Castanotto D,Li H,Rossi JJ.Functional siRNA expression from transfected PCR products[J].RNA,2002,8(11):1 454
5. Sui G,Soohoo C,Affarel B,et a1.A DNA vector based RNAi,technology to suppress gene expression in mammalian cells[J].Proc Natl Acad Sci U S A,2002,99(8):5 515-5 520。
6. Paddison PJ,Caudy AA,Hannon GJ.Stable suppression of gene expression by SiRNA in mammalian cells.Proc Natl Acad Sci U S A 2002;99(3):1443-8
7. Yang SH,Tutton S,Yoon K.Specific Double-Stranded RNA Interference in Undifferentiated Mouse Embryonic Stem Cells.Molecular and Cellular Biology.2001; 21:7807-7816
8. Xia HB,Mao QW,Paulson HL,Davidson BL.SiRNA mediated gene silencing in vitro and in vivo.Nat Biotechnol 2002;20:1006-1010
1. Wang D,Jing N,Lin Q.Stearylamine liposome as a new efficient reagent fox DNA transfection of eukaryotic cells.Biochem Biophy Res Co m mu,1996,226(2):450-455
2. Jaaskelainen 1,M onkkonen J,U rttiA.Oligonucleotide cationicliposome interaction.A physicochem ical study[J]Biochim Biaphus Acta,1994,1195(l):115-123。
3. Stamatutos L et al.Interactions of cationic lipid vesicles with negatively charged phosphollpld vesicles and biology membranes[J]Biochemistry,1 988,27:3917-3925
4. Fashnan SJ,Tousigant JD,I Aason M1,et al.Optimivation of fonnulatians and conditions for the aerosol delivery of functional cationic lipid:DNA cotnlexes.Hum Gene ner,1997;8:313-322
5. Felgner PL.Improvements in cationic liposomes for in vivo gene transfer.Hum Gene'Iher,1996;7:1791-1793
6. Weber M,M oller K,W elzeck M,et al.Short technical reports Effects of lip opolysaccharide on transfection efficiency in eukaryotic cells[J].B iotechniques,1995, 19(6):930-940.
7. Mac Gregor G.Optimizxing of electroporation using reporter genes.In Chang DC·Chassy BM·Saunders JAand Sowers AE(Eds).Academic Press Guide to Electroporation and Electrofusion. Academic Press.San Diego.1992.P.465-470.
8. Chalfie M,Tu Y,Euskirchen G,et al.Green fluorescent protein as a marker fox gene expression[J]. Science,1994,263:802-805
1. Fire A,Xu S,Montgomery Mc et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans,Nature,1998,391:806-811.
2. NICHOLDNR H,NICHOLDN A W.Molecular characterization Of a mouse cDNA encoding Dicer,a ribonucleaseⅢortholog involved in RNA interference[J].Mann Genome,2002,13(2);67-73.
3. ELBASHIR S M,HARBORTH J,WEBER K,et a1.Analysis Of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,(26),199-213
4. SABINE B.Antisense 2 RNA regulation and RNA interference[J].Biochemica et Biophysica Acta, 2002,1575:15-25.
5. SUI G,SOOHOO C,AFFAIR E B,et al.A DNA vector2 based RNAi technology to suppress gene expression in mammalian cells[J].Genetics,2002,99(8),5515--5520.
6. ELBASHIR S M,HARBORTH J,WEBER K,et a1.Analysis Of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,(26),199-213
7. SlJEN T,FLEENOR J,SIMMER F,et al.On the role of RNA Amplification in dsRNA2 triggered gene silencing[J].Cell,2001,107(4),465-476.
8. LIPARDI C,WEI Q,PATERSON B M.RNAi.as random degradative PCR:siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNA[J]. Cell,2001,107(3):297--307.
9. Ngo H,Tschudi C,Gull K,et al.Double 2 stranded RNA induces mRNA degradation in Trypanosoma brucci.Proc Natl Acad Sci USA,1998,95(25):14687-14692.
10. Montgomery MK,Xu S,Fire A.RNA as a target of double stranded RNA mediated genetic interference in Caeanorhabditis elegans.Proc Natl Aced Sci USA,1998, 95(25): 15502--15507.
11. Har Dorth J,Elbashir SM,Bechert K,et al.Identification of essential genes in cultured mammalian cells using small interferingRNAs.J Cell Sci,2001,114:4557--4565.
12. Yang D,Lu H,Erickson JW,Evidence that processed small dsRNAs may mediate sequence2specific mRNA degradation duringRNAi in Drosophila embryos.Curr Biol,2000,10(19):1191--1200.
13. Sabine B.Antisense RNA regulation and RNA interference.Biochem Biophys Acta,2002,1575 (123):15225.
14. Gan L,Anton KE,Masterson BA,et al.Specific interference with gene expression and gene function mediated by long double stranded RNA in neural cells.J,2000, 9(18):1198--1208.
1. Pham NA, Tsao MS, Cao P et al. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pancreas. 2007 Oct;35(3):e16-26
2. Hanada M et al.Biochim Biophys Acta,2004。1697(1-2):3-16
3. Tokuda E, Fujita N, Oh-hara T et al. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein,down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res. 2007, Oct 15;67(20):9666-9676
4. Brownawell AM,Kops GJ, Macara IG et al. Inhibition of nuclear import by protein kinase B(Akt)regulates the subcellular distribution and activity of the forkhead transcription factot AFX.Mol Cell Biol. 2001;21:3534-3546
5. Liang J,Zubovitz J, Petrocelli T et al. PKB/Akt phosphorylates p27,impairs nuclear import of p27 and opposes p27-mediated G1 arrest.Nat Med.2002;8:1153-1160
6. Fujita N,Sato S,Katayama K et al.Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.J Biol Chem.2002 ;277:28706-28713
7. Li Y, Dowbenko D,Lasky LA.AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem.2002;277:11352-11361
8. Skeen JE, Bhaskar PT, Chen CC et al. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell. 2006 Oct;10(4):269-80
9. Gao N,Flynn DC,Zhang Z,et a1.The G1 cell cycle progression and the expression of Gl cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells[J].Am JPhysiol Cell Physiol,2004,287(127):C281-C291.
10. ShioiT,McMullenJR,KangPM,et al.Akt/protein kinaseB promotes organ growth in transgenic mice.Mol Cell Biol.2002,22(8):2799-2809
11. Faridi J,Fawcett J,Wang L,et al.Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation.Am J Physiol Endocrinol Metab.2003,285(5):E964-972
12. Reif S,Lang A,Lindquist JN,et al.The role focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type l collagen expression. J Biol Chem.2003,278(10):8083-8090
13. Jetzt A,Howe JA,Horn MT,et al.Adenoviralmediated expression of a kinase dead mutant of Akt induces apoptosis selectively intum or cells and suppresses tumor growth in mice [J].Cancer Res,2003,63(20):6697-706.
14. Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation Ericson K, Gan C, Cheong I, Rago C, Samuels Y, Velculescu VE, Kinzler KW, Huso DL, Vogelstein B, Papadopoulos N.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2598-603. Epub 2010 Jan 20.
15. Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. Kirkegaard T, Witton CJ, Edwards J, Nielsen KV, Jensen LB, Campbell FM, Cooke TG, Bartlett JM. Histopathology. 2010 Jan;56(2):203-11
16. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Fortin SP, Ennis MJ, Savitch BA, Carpentieri D, McDonough WS, Winkles JA, Loftus JC, Kingsley C, Hostetter G, Tran NL.Mol Cancer Res. 2009 Nov;7(11):1871-81. Epub 2009 Oct 27
17. Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.Al-Saad S, Donnem T, Al-Shibli K, Persson M, Bremnes RM, Busund LT.Anticancer Res. 2009 Oct;29(10):4175-83
18. The expression of oncogene AKT2 in laryngeal squamous cell carcinoma and its clinical significance]Chen Y, He Y, Zhang S, Li L, Zhu X, Liu Y.Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Jun;23(12):539-41, 545. Chinese
19. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma. Iamaroon A, Krisanaprakornkit S. Oral Oncol. 2009 Oct;45(10):e175-9. Epub 2009 Jul 22
20. Medema RH,Kops GJ,Bos JL,et a1.AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kipl[J].Nature,2000,404 (6779):782-787.
21. Gagnon V.St-Germain ME,Parent S,et a1.Akt activity in endometrial cancer cells:regulation of cell survival through cIAP-1[J].Int J Oncol,2003,23(3):803-810.
22. Dan HC,Sun M ,Kaneko S,et a1.Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein(XIAP)[J].J Biol Chem,2004,279(7):5405-5412.
23. Alberts B,et al.Molecular Biology of the Cell.4th ed.New York&London:Carland Publishing Inc, 2002
1. Yeatman TJ,Nicolson GL.Molecular basis of tumor progression:mechanisms of organ-specific tumor metastasis[J].Semin Surg Oncol,1993,9(3):256-263.
2. Aznavoorian S,Murphy AN,Stetler-stevenson WG,et al.Molecular aspects of tumor cell invasion and metastasis[J].Cancer,1993,71(4):1368
3. Kim D,Kim S,Koh H,et al.Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production[J].FASEB J,200l,15(11):1953-1962
4. Yamamoto Y,Tsutsumi Y,Mayumi T.Molecular design of bioconljugated cell adhesion peptide with a water soluble polymeric modifier for enhancement of an time tastatic effect[J].Curr Drug Targets,2002,3(2):123
5. A rihro K,InaiK,Kurara K.Distribution of laminin,typeⅣcollagen and fibronectin in the invasive component of breast carcinoma.Acta Pathol Jpn Dec,1993;43:758
6. Kibbey MC,Grant DS,Kleinman HK.Role of file SIKVAV site of laminin in plarmfion of angiogenesis and tumor growth:All in vivo Matfigel model[J].J Natl CancerInst(Bethesda), 1992;84:1633-1638.
7. DeRoock B,Pemfington ME,Stuka TC,et al.Synthetic pepfdes inhibit adhesion of human tumor cells to extracellular matrix proteins[J].Cancer Res,2001;61(8): 3308-3313.
8. Carlod PS,Norman HA,Parmender P,et al.Prostate cancer progression,metastasis,and gene expression in transgenis mice.Cancer Res,1 997,57:900-907.
9. Hee J,Sook B,Ho Y,et al.Anti-invasive activity of solie and correlates with the reduced expression of matrix met all op rote ninnase-9(MMP-9)in HT-1080 human fibrosarcoma cells.Cancer Res, 1996,56:2281-2285.
10. Allgayer H,Babic K,Beyer BC,et al.Prognostic relevance of MMP-2(72kDconagenase IV)in gastric cancer[J].Oncology,1998,55(2):152.
11. Aznavoorian S,Murphy AN,Stetler Stevenson WG,et al.Molecelular suspects of tumor cell invasion and metastasis[J].Cancer,1993,71:1368
12. Dunn SE,Torres JV,Oh JS,et al.Up-regulation of urokinase type plasminogen activator by insulin-like growth factor-I depends upon phosphatidytinositol-3 kinase and mitogen-activated protein kinase[J].Cancer Res,2001,61(4):1367-1374.
13. Fujihara T,Sawada R,Hirskawa K,et al.Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis.Clin Exp Metastasis,1998,16:389-398
14. Yoong KF,Me Nab G,Hubscher SG.Vascular adhesion protein and ICAM-1 support the adhesion of tumor in filtrating lymphocytes to tumor endothelium in human hepatocellular carcinoma.J I m munol,1998,160:3978-3988
15. Albelda S M,Buck CA.Integrins and other cell adhesion molecules.FASEB J,1996,17:71-81
16. Liotta LA,Wewer U,Rao NC et al.Bio chemical mechanisms of to more invasion and metastases. Adv Exp Med Biol,1988,233:161
17. Pellegrinl R,Martignone S,Tagliabue E et al.Prognostic significance of laminin production in relation with its receptor expression in human breast carcinoma.BreastCancer Res Treat,1995,35:195
18. Marques LA,Franco ELF,Torloni H et al.Independent prognostic value of laminin receptor expression in breast cancer survival.Cancer Res,1990,50:1 870
19. MareelM , B racke M&VanRoy F.Cancer metastasis:negative regulation by an invasion-suppressor complex.Cancer Detect P rev,1995,19(5):451.
20. Dunn SE,Ehrlich M,Sharp NJ,et al.A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion,invasion,and metastasis of breast cancer[J].Cancer Res,1998,58(15):3353-3361.
1. Nam SY,Jung GA,Hur GC,et a1.Upregulation of FLIP(S) by Akt,a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers[J]. Cancer Sci,2003,94(12):1066-1073.
2. Bommhardt U et a1.J Immunol,2004,172(12):7583-7591
3. Inayat-Hussain,Couet SHC,Cohen GM,et al.Processing/activation of CPP32-1ike proteases is involved in transforming growth factor is induced apoptosis in rat hepatocytes.Hepatology 1997;25:1516-1523.
4. Ekert PG,Silke J,Vaux DL.Caspas-3 inhibitors.Cell Death Differ 1999;6:1081-1086.
5. Patel T,Gores G.Apoptosis and hepatobiliary disease Hepatology,1995,21:1725-1741
6. Ledda Columbano GM,Coni P,Curto M,et al.Induction of two different modes of cell death,apoptosis and necrosis,in rat liver after a single dose of thioacetamide.Am J Patho1,1991,139(5):1099-1109
7. Laddar Columbano GM,Coni P,Faa G,et a1.Rapid induction of apoptosis in rat liver by cycloheximide.Am J Patho1,1992,140(3):545-549.
8. Kimura K,Yamamoto M.Modification of the alternative splicing process of testosterone-repressed prostate message-2(TRPM2)gene by protein synthesis inhibitors and heat shock treatment.Biochim Biophys Acta,1996,1307(1):83-88
9. Esolen L M,Sukw P,Jm arle H,et al.Apoptosis as a cause of death in meases virus-infected cells.J Virology,1995,169(6):3955-3958
10. DeZhong L,YouXin J,Hua FI,et al,Preparation and identification of activity ofanti-HPV-6b/l 1E 1 universal ribozyme-Rzl 198 in vitro.Asian Journal of Andrology 1999;1:195-201.
11. Uhlenbeck OC.A small catalytic oligoribonucleotide.Nature 1987;328:569-600.
12. Teodoro JG,Branton PE.Regulation of apoptosis by viral gene products.J Virol,1997,71:1739-1746.
13. Phylaetou LA,Kilpatrick Mw,Wood MI.Ribozyraes as therapeutic tools for genetic disease.Hum Mol Genet,1998;7(10):1649-1653.
14. O rter A O and Janicke R U.Emerging roles of easpase-3 in apoptosis.Cell Death Differ,1999,6:99-104
15. Y.Du,R.C.Dodei,K.R.Bales,R.Jemmerson,E.Hamilton-Byrd,and S.M.Involvement of a caspase-3-1ike cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons,J.Neurochem 69(1997)1382-1388.
16. R.Klara,Birikh,A.Paul,HEATON and E.Fritz,The structure,function and application of the hammerhead ribozyme,Eur.J.Biochem.245(1997)1-16.
17. K.Kuida,T.S.Zheng,S.Na,CY.Kuan,D.Yang,H.Karasuyama,P.Rakie and R.A.Flavell, Decreased apoptosis in the brain and premature lethality in CPP32-dcficient mice,Nature 384(1996) 368-372.
18. S.A.Loddick,A.MacKenzie,and N.J.RothwcU,An ICE inhibitor,z-CAD-DCB attenuates ischaemic brain damage in the rat,Neuroreport.9(1996)1465-1468.
19. S.J.Martin,D.R.Green,Protease activation during apoptosis:death by a thousand cuts7 Cell 82 (1995)349-352.
20. J.C.Martinou and R.Sadoa,ICE-like proteases execute the neuronal death program,Curr.Opin. Neurobiol.6(1996)609-614.
21. J.C.Mayo,R.M.Sainz,I.Antolin,C.Rodriguez,Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage,Brain Res.818(1999)221-227.
22. N.J.McCarthy,L.L.Rubin,and K.L.Philpott,Involvement of caspases in sympathetic neuron apoptosis,J.Cell Sci.l 10(1997)2165-2173.
23. Reed JC.Double identity fox proteins of the Bcl-2 family.Nature,1 997,387:773-776
24. Leung LK,Wang TT.Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway inhuman breast cancer cell line MCF Breast Cancer Res Treat,1999,55:73-83
25. Gibson LF,Fortney J,Magro G,et al.Regulation of Bax and Bcl-2 expression in breast cancer cells by chemotherapy.Breast Cancer Res Treat,1999,55:107-117
26. Nakata B,Muguru ma K,Hirakawa K,et al.Predictive value of Bcl-2 and Bax protein expression for the motherapeutic effect in gastric cancer.On cology,1998,55:543-547
1.刘平,赵志泉,张小勇等。人胃癌组织块裸鼠原位移植/转移模型的建立。肿瘤防治与研究,2001:28:15-16。
2. FerraraN,Chen H,Davis-SmythT,et a1.Vascular endothelial growth factor is essential for corpus luteum angiogenesis[J].Nat Med,1998,4(3):336-340.
3. Bmstmann H,Naude S.Vascular endothelial growth factor expression in serellS ovarian carcinoma : relationship with high mitotic activity and hish FIGO stage(J].cynec0l Oneol,2002,84(1):47-52.
4. Arboleda MJ, Lyons JF, Kabbinavar FF, et al. Overexpression of AKT2/protein kinase Bh leads to upregulation of h1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 2003;63:196–206.
5. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007;67:1979–87.
6. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 2005;20:539–50.
7. Irie HY, Pearline RV, Grueneberg D, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005;171: 1023–34.
8. Fortin SP, Ennis MJ, Savitch BA, Carpentieri D, McDonough WS, Winkles JA, Loftus JC, Kingsley C, Hostetter G, Tran NL. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Mol Cancer Res. 2009 Nov;7(11):1871-81.
1. Pham NA, Tsao MS, Cao P et al. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pancreas. 2007 Oct;35(3):e16-26
2. Hanada M et al.Biochim Biophys Acta,2004。1697(1-2):3-16
3. Tokuda E, Fujita N, Oh-hara T et al. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein,down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res. 2007, Oct 15;67(20):9666-9676
4. Brownawell AM,Kops GJ, Macara IG et al. Inhibition of nuclear import by protein kinase B(Akt)regulates the subcellular distribution and activity of the forkhead transcription factot AFX.Mol Cell Biol. 2001;21:3534-3546
5. Liang J,Zubovitz J, Petrocelli T et al. PKB/Akt phosphorylates p27,impairs nuclear import of p27 and opposes p27-mediated G1 arrest.Nat Med.2002;8:1153-1160
6. Fujita N,Sato S,Katayama K et al.Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.J Biol Chem.2002 ;277:28706-28713
7. Li Y, Dowbenko D,Lasky LA.AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem. 2002; 277:11352-11361
8. Skeen JE, Bhaskar PT, Chen CC et al. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell. 2006 Oct;10(4):269-80
9. Gao N,Flynn DC,Zhang Z,et a1.The G1 cell cycle progression and the expression of Gl cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells[J].Am JPhysiol Cell Physiol,2004,287(127):C281-C291.
10. ShioiT,McMullenJR,KangPM,et al.Akt/protein kinaseB promotes organ growth in transgenic mice.Mol Cell Biol.2002,22(8):2799-2809
11. Faridi J,Fawcett J,Wang L,et al.Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation.Am J Physiol Endocrinol Metab.2003,285(5):E964-972
12. Reif S,Lang A,Lindquist JN,et al.The role focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type l collagen expression. J Biol Chem.2003,278(10):8083-8090
13. Jetzt A,Howe JA,Horn MT,et al.Adenoviralmediated expression of a kinase dead mutant of Akt induces apoptosis selectively intum or cells and suppresses tumor growth in mice [J].Cancer Res,2003,63(20):6697-706.
14. Maeda H et a1.Transplant Proc,2004,36(4):l163-1165
15. West KA,Brognard J,Clark AS,et a1.Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells[J].J Clin Invest,2003,111(1):81-90.
16. Nam SY,Jung GA,Hur GC,et a1.Upregulation of FLIP(S) by Akt,a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers[J]. Cancer Sci,2003,94(12):1066-1073.
17. Bommhardt U et a1.J Immunol,2004,172(12):7583-7591
18. Medema RH,Kops GJ,Bos JL,et a1.AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kipl[J].Nature,2000,404 (6779):782-787.
19. Gagnon V.St-Germain ME,Parent S,et a1.Akt activity in endometrial cancer cells:regulation of cell survival through cIAP-1[J].Int J Oncol,2003,23(3):803-810.
20. Dan HC,Sun M ,Kaneko S,et a1.Akt Phosphorylation and Stabilization of X-linkedInhibitor of Apoptosis Protein(XIAP)[J].J Biol Chem,2004,279(7):5405-5412.
21. Zhou X,Tna M,Stone Hawthorne V,et a1.Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 over expression predicts tumor progression in breast cancers.Clin Cancer Res,2004,10(20):6779-678 8
22. Dimmeler S,Zeiher AM.Akt takes center stage in angiogenesis signaling.Circ Res,2000,86(1):4-5.
23. Healh D,Skinner, Jenny ,et al.Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-inducible Factor 1α,HDM2,and P70S6Kl in Response to Phosphatidylinositol 3-kinase/AKT Signaling.J Biol Chem,2004,279(44):45643-45651
24. Zhong XS,Zheng JZ,Reed E,et al,SU5416 inhibited VEGF and HIF-1 expression through the PI3K/PKB/P70s6kl signaling Pathway Biochernical and Biophysical Research.Communications,2004,324:471-480
25. Gao N,Nester RA,Sarkar MA,et al.4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor lalpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/AKT/FRAP pathway in OVCAR-3 and A2780-CP70 hunman ovarian carcinoma cells.Toxicol Appl Pharmacol,2004,196(1):124-135
26. ZHONG H,CHILES K,FELDSER D,et a1.Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/Akt/FRAP pathway in human prostate cancer cells:implications for tumor angiogenesis and therapeutics[J].Cancer Res,2000,60(6):1541-1545
27. Nakashio A,Fujita N,Tsuruo T.Topotecan inhibits VEGF-and bFGF-induced vascular endothelial cell migration via down regulation of the PI3K-Akt signaling pathway[J]. Int J Cancer,2002,98(1):3641
28. Matei D,Kelich S,Cao L,et a1.PDGF BB induces VEGF secretion in ovarian cancer[J].Cancer Biol Ther,2007,6(12):1951-9
29. Cao Z , Liu LZ , Dixon DA , et a1 . Insulin-like growth factor-I inducesCyclooxygenase-2 expression via P13K,MAPK and PKC signaling pathways in human ovarian cancer cells[J].Cell Signal,2007,19(7):1542-53
30. Larue L,Bellacosa A,Epithelial-mesenchymlal transition in development and cancer: role of phosphatidylionsitol 3-kinase/AKT pathways.Oncogene, 2005, 24(50): 7443- 7454
31. CINDY YF,JEFFERY JW,KYMBERLEY LS,et al.Inhibition of integrin-linked kinase by a selective small molecule inhibitor,QLT0254,inhibits the PI3K/PKB/mTOR . STAT3,and FKHR pathways and tumor growth , and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts[J].Cancer Res,2005,65(4):1497-1504.
32. KIM MS,PARK MJ,MOON EJ,et a1.Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells[J].Cancer Res,2005,65(3):686-691
33. Kim CS,Vasko VV,Kato Y,et al.AKT activation promotes metastasis in a mouse model offollicular thyroid carcinoma [J ].Endocrinology,2005,146(6):4456-4463.
34. Kim D,Kim S,Koh H,et al.Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production[J].FASEB J,200l,15(11):1953-1962
35. Zhang D,Brodt P.Type l insulin-llke growth factor regulates MTl-MMP synthesis and tumor invasion via PI3-kinase/Akt signaling[J].Oncogene,2003,22(7):974-982
36. Tanno S,Tanno S,Mitsuuchi Y,et al.AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasivenessof human pancreatic cancer cells[J].Cancer Res,2001,61(2):589-593
37. Hill MM,Hemmings BA. Inhibition of protein kinase B/AKT implications for cancer therapy[J].Pharmacol Ther,2002,93(3):243-251.
38. Nakanishi K , Sakamoto M , Yasuda J , et a1 . Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer[J].Cancer Res,2002,62(10):2971-2975
39. BONDAR VM,SWEENEY-GOTSCH B,ANDREEFF M,et a1.Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo[J].Mol Cancer Ther,2002,l(12):989-997.
40. TAN J,HALLAHAN D E.Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response[J].Cancer Res,2003,63(22):7663-7667
41. CLARK A S,WEST K,STREICHER S,et al.Constitutive and inducible Akt activity promotes resistance to chemotherapy,trastuzumab,or tamoxifen in breast cancer cells[J].Mol Cancer Ther,2002,1(9):707-717.
42. SHINGU T,YAMADA K,HARA N, et a1.Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells[J].Cancer Res,2003,63(14):4044-4047.
43. West KA,Brognard J,Clark AS,et a1.Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells[J].J Clin Invest,2003,111(1):81-90.
44. GUPTA AK,BAKANAUSKAS VJ,CERNIGLIA GJ,et a1.The Ras radiation resistance pathway[J].Cancer Res,2001,6l(10):4278-4282.
45. SAKUNTALA W G,JULIE L,ELISABETH B,et a1.The insulin-like growth factor-I receptor kinase inhibitor,NVP-ADW742,sensitizes small cell lung cancer cell lines to the effects of chemotherapy[J].Clin Cancer Res,2005,11(15):1563-1571
46. Larson SD, Jackson LN, Riall TS et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg. 2007 May;204(5):764-773; discussion 773-775. Epub 2007 Feb
47. An HJ, Cho NH, Yang HS, et al. Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells. J Pathol. 2007 Jun;212(2):161-169.
48. Cheng GZ, Chan J, Wang Q et al. Twist transcriptionally up-regulates AKT2 in breastcancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res. 2007 Mar 1;67(5):1979-1987.
49. Zhang M, Fang X, Liu H et al. Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chloro-2-methylellipticinium acetate (CMEP). Biochem Pharmacol. 2007 Jan 1;73(1):15-24. Epub 2006 Sep
50. Maroulakou IG, Oemler W, Naber SP,et al. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 2007 Jan 1;67(1):167-177